ASH2022 - abstracts are now listed on the conf... - CLL Support
ASH2022 - abstracts are now listed on the conference website
You need to be a member of this community to see this post.
Read more about...
27 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Zanubrutinib vs. Ibrutinib Patient Power Video by Dr. Jennifer Brown MD PHD
In this Patient Power video - Dr. Brown is very clear about the advantages of Zanubrutinib over...
ASH Conference Speaker: Diet valuable in reducing Inflammation and Symptom Burden in People with Blood Disorders
OK, so I'm one part blown away, one part grateful and one little part "I told you so!"
In a Patient...
ASH 2013: Dr. John Pagel Speculates on the Future of CLL Therapies including the late breaking data on Idelalisib
ASH 2013: Dr. John Pagel Speculates on the Future of CLL (chronic lymphocytic leukemia) Therapies...
2022 ASH Conference Report: Should MPN Patients Follow the Mediterranean Diet?
I am glad to see some work presented on the topic of diet at 2022 ASH… I personally embarked on...
CLL SOCIETY'S ASH POSTER on our Free second opinion program plus two important papers from ASCO
Hi,
Just back from a frenetic and fantastic ASH, but still have news to share from ASCO.
But first...
Related Posts
- ASH 2018: Dr. Chadi Nabhan on the Cost of Ibrutinib vs. Chemo vs Chemoimmunotherapy in CLL and on way too much chemo being used.
- Dr. Wierda on the Importance of Clinical Trials
- Hospice / Pallative Care / Supportive Care for Blood Cancer patients is not suggested soon enough
- CLL Society' s abstract on what we want in our disease management published today in the ASH CLL abstracts.
- ASH 2018 and More
